HUMAN MYELOPEROXIDASE TRENDS AND INDUSTRY UPDATES

    /24-7PressRelease/ - SAINT LOUIS, MO, September 20, 2007 - www.leebio.com Lee Biosolutions, Inc has increased manufacturing capacity for Human Myeloperoxidase and Myeloperoxidase isoforms A/B and isoform C due to increase demand for the clinical diagnostic, pharmaceutical manufacturers and researchers worldwide.

Current research on Myeloperoxidase protein explains how a single initial measurement of plasma myeloperoxidase (mpo), which is found in white blood cells, independently predicts the early risk of cardiovascular disease. In addition,research suggests that myeloperoxidase levels can predict the risk of major adverse cardiac events such as ischemia, myocardial infarction, and congestive heart failure, as well as heart cancer, Multiple Sclerosis, and other ailments.

Human Myeoloperoxidase MPO Isoform C is a popular enzyme among the community of protein structural researchers, including X-ray crystallographers. According to company President, Burton Lee, " we have been able to isolate and purify Myeloperoxidase Isoform C utilizing our innovative purification methodologies for major diagnostic and pharmaceutical companies worldwide".

Lee Biosolutions is in constant communication with its customers to determine trends and anticipate product needs before they happen. Research and Development has played a large part in the growth of Lee Biosolutions.

We understand the critical role our products play in the clinical research process, Lee said. By maintaining higher purity and quality standards, we aim to provide clients with a wider variety of reliably consistent products which makes us the preferred producer of Myeloperoxidase proteins and antibodies.

According to Lee, Myeloperoxidase is only one of several cardiac markers which have been in high demand for some time. Lee Biosolutions supplies Native Human Myeloperoxidase, Native and recombinant Human Cardiac Troponin I,T,C, Human Creatine Kinase isoenzyme MB (CKMB) and CK MM, Lactate Dehydrogenase, Serum Amyloid P, APO A1 lipoprotein(s),human heart Myoglobin, proBNP,Alpha fetoprotein,and many other human proteins.

Lee Biosolutions is a leader in the purification of high quality animal and human proteins to the clinical diagnostic IVD manufacturer and researchers around the world, developing tomorrows cures. Orders can now be placed on our website at www.leebio.com

About Lee Biosolutions, Inc
Lee Biosolutions, Inc specializes in the development and purification of high quality BioMarkers for the Immunodiagnostic, clinical diagnostic and pharmaceutical industry worldwide. We supply reliable high quality human and animal enzymes and proteins, cardiac markers, tumor markers, acute phase proteins, coagulation proteins and immunoassay biomarkers. For further information, please contact us at 314.968.1091

# # #